Teza Capital Management’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
– Sell
-2,551
Closed -$349K – 327
2025
Q1
$349K Buy
+2,551
New +$365K 0.16% 218
2024
Q2
– Sell
-1,654
Closed -$357K – 587
2024
Q1
$357K Buy
+1,654
New +$387K 0.05% 405
2023
Q4
– Sell
-10,664
Closed -$2.74M – 562
2023
Q3
$2.74M Buy
10,664
+8,832
+482% +$2.36M 0.45% 52
2023
Q2
$522K Buy
+1,832
New +$545K 0.08% 283
2023
Q1
– Sell
-8,074
Closed -$2.24M – 515
2022
Q4
$2.24M Buy
8,074
+3,908
+94% +$1.1M 0.43% 47
2022
Q3
$1.11M Buy
+4,166
New +$885K 0.23% 120
2022
Q2
– Sell
-5,817
Closed -$1.23M – 426
2022
Q1
$1.23M Buy
+5,817
New +$1.26M 0.46% 50
2021
Q4
– Sell
-2,495
Closed -$706K – 438
2021
Q3
$706K Sell
2,495
-4,922
-66% -$1.61M 0.34% 86
2021
Q2
$2.57M Buy
+7,417
New +$2.25M 0.42% 67
2021
Q1
– Sell
-2,090
Closed -$512K – 469
2020
Q4
$512K Buy
+2,090
New +$539K 0.29% 122
2020
Q3
– Sell
-6,604
Closed -$1.77M – 387
2020
Q2
$1.77M Buy
+6,604
New +$1.99M 0.39% 59
2020
Q1
– Sell
-3,313
Closed -$983K – 160
2019
Q4
$983K Sell
3,313
-1,329
-29% -$369K 0.27% 99
2019
Q3
$1.08M Buy
+4,642
New +$1.08M 0.28% 115
2018
Q3
– Sell
-3,468
Closed -$1.01M – 383
2018
Q2
$1.01M Sell
3,468
-256
-7% -$72K 0.15% 237
2018
Q1
$1.02M Buy
3,724
+819
+28% +$254K 0.25% 141
2017
Q4
$925K Buy
+2,905
New +$932K 0.56% 29

Other funds holding BIIB

Teza Capital Management's BIIB Position: Q2 2025 in Review

Teza Capital Management sold out of Biogen (BIIB) in Q2 2025, closing a stake of 2,551 shares — an estimated $349K sold.

Teza Capital Management first reported a position in BIIB in Q4 2017 and held it in 16 quarters. The position peaked at $2.74M in Q3 2023. 866 funds tracked by Wall St. Rank hold BIIB as of Q2 2025.

  • Teza Capital Management reported no remaining Biogen position as of Q2 2025 after selling out during the quarter.
  • Teza Capital Management sold 2,551 Biogen shares in Q2 2025, an estimated $349K.
  • Teza Capital Management first reported a position in Biogen in Q4 2017 and held it in 16 quarters.
  • Teza Capital Management's Biogen position peaked at $2.74M in Q3 2023.
  • 866 funds tracked by Wall St. Rank held Biogen as of Q2 2025.

Based on Teza Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.